Author:
Alyamani Mohammad,Alshehri Sultan,Alam Prawez,Ud Din Wani Shahid,Ghoneim Mohammed M.,Shakeel Faiyaz
Funder
King Saud University Deanship of Scientific Research
King Saud University
Reference40 articles.
1. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism;Ravi;Eur. J. Pharm. Biopharm.,2014
2. Antileishmanial activity of the estrogen receptor modulator raloxifene;Reimão;PLoS Negl. Trop. Dis.,2014
3. Pharmacokinetics of raloxifene and its clinical application;Hochner-Celnikier;Eur. J. Obstet. Gynecol. Reprod. Biol.,1999
4. Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation;Jha;AAPS PharmSciTech.,2011
5. D. Saini, M. Fazil, M. Ali, S. Baboota, Ameeduzzafar, J. Ali, Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis, Drug Deliv. 22 (2015) 823–836.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献